CLINICAL TRIALS PROFILE FOR ELAVIL
✉ Email this page to a colleague
All Clinical Trials for Elavil
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000428 ↗ | Combining N-of-1 Trials to Assess Fibromyalgia Treatments | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Phase 4 | 2000-09-01 | This study will compare the effectiveness of combination therapy with the drugs amitriptyline and fluoxetine (AM+FL) and amitriptyline (AM) alone in the treatment of people with fibromyalgia. Doctors will treat each study participant with both AM + FL and AM alone for 6 weeks at a time. The study uses a method that combines results from treatment of individual patients to assess overall treatment effectiveness and help individual patients and their physicians with their treatment decisions. This study will also help compare the results of community-based studies (studies involving private doctors) and studies based at clinical research centers. |
| NCT00000428 ↗ | Combining N-of-1 Trials to Assess Fibromyalgia Treatments | Completed | Tufts Medical Center | Phase 4 | 2000-09-01 | This study will compare the effectiveness of combination therapy with the drugs amitriptyline and fluoxetine (AM+FL) and amitriptyline (AM) alone in the treatment of people with fibromyalgia. Doctors will treat each study participant with both AM + FL and AM alone for 6 weeks at a time. The study uses a method that combines results from treatment of individual patients to assess overall treatment effectiveness and help individual patients and their physicians with their treatment decisions. This study will also help compare the results of community-based studies (studies involving private doctors) and studies based at clinical research centers. |
| NCT00248651 ↗ | Functional Dyspepsia Treatment Trial | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2/Phase 3 | 2006-10-01 | Functional dyspepsia is a common gastrointestinal disorder. Symptoms can include stomach pain or discomfort, bloating, fullness after eating meals, and nausea. These symptoms often interfere with school and work, and weight loss may occur due to dietary restrictions. The hypothesis of this study was that antidepressant therapy is more effective than placebo in relief of the symptoms of functional dyspepsia, adjusting for psychological and psychiatric co-morbidity. The study also examined if antidepressant therapy reduces disability and improves quality of life in functional dyspepsia. |
| NCT00248651 ↗ | Functional Dyspepsia Treatment Trial | Completed | Mayo Clinic | Phase 2/Phase 3 | 2006-10-01 | Functional dyspepsia is a common gastrointestinal disorder. Symptoms can include stomach pain or discomfort, bloating, fullness after eating meals, and nausea. These symptoms often interfere with school and work, and weight loss may occur due to dietary restrictions. The hypothesis of this study was that antidepressant therapy is more effective than placebo in relief of the symptoms of functional dyspepsia, adjusting for psychological and psychiatric co-morbidity. The study also examined if antidepressant therapy reduces disability and improves quality of life in functional dyspepsia. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Elavil
Condition Name
Clinical Trial Locations for Elavil
Trials by Country
Clinical Trial Progress for Elavil
Clinical Trial Phase
Clinical Trial Sponsors for Elavil
Sponsor Name
